Fed. Circ. Says Consumer Group Can't Fight Stem Cell Patent
The Federal Circuit on Wednesday dismissed an appeal by a consumer group aimed at invalidating the first four claims of a patent for human embryonic stem cells, finding the organization doesn't...To view the full article, register now.
Already a subscriber? Click here to view full article